APA
LENZ

American Portfolios Advisors’s LENZ Therapeutics LENZ Stock Holding History

American Portfolios Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$63 Hold
3
– – ﹤0.01% 3495
2022
Q2 		$55 Sell
3
-36
-92% -$803 ﹤0.01% 3500
2022
Q1 		$1.38K Hold
39
– – ﹤0.01% 3301
2021
Q4 		$3.36K Buy
39
+36
+1,200% +$2.98K ﹤0.01% 3028
2021
Q3 		$328 Buy
+3
New +$444 ﹤0.01% 3408

Other funds holding LENZ

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

American Portfolios Advisors's LENZ Position: Q3 2022 in Review

American Portfolios Advisors held its LENZ Therapeutics (LENZ) position steady in Q3 2022 at 3 shares worth $63. The position accounts for ﹤0.01% of the portfolio, ranked #3495.

American Portfolios Advisors first reported a position in LENZ in Q3 2021 and has held it in 5 quarters since. The position peaked at $3.36K in Q4 2021. 63 funds tracked by Wall St. Rank hold LENZ as of Q3 2022.

  • American Portfolios Advisors held 3 shares of LENZ Therapeutics worth $63 as of Q3 2022.
  • American Portfolios Advisors left its LENZ Therapeutics share count unchanged in Q3 2022.
  • LENZ Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3495 holding.
  • American Portfolios Advisors first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • American Portfolios Advisors's LENZ Therapeutics position peaked at $3.36K in Q4 2021.
  • 63 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.